Scientists have developed an adaptable materials platform that can safely and efficiently deliver a wide range of genetic medicines, an advance that could accelerate the development of next-generation vaccines, cancer treatments, and gene-silencing drugs. Experts from the University of Nottingham's School of Pharmacy have created a new drug delivery platform that uses modular building blocks that self-assemble with ribonucleic acid- RNA to form nanoscale delivery particles. The research has been published in Advanced Materials.